Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04789408
Title Study Evaluating the Safety of KITE-222 in Participants With Relapsed/Refractory Acute Myeloid Leukemia
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Gilead Sciences

acute myeloid leukemia


Cyclophosphamide + Fludarabine + KITE-222

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.